Entero Healthcare Solutions: The financial results for the period ended September 30, 2026
Entero Healthcare Solutions (ENTERO) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹7,247 crore.
What happened
Entero Healthcare Solutions (ENTERO) filed a disclosure with the exchanges on 4 November 2026 at 08:14 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
Entero Healthcare Solutions is a small-cap company in the Consumer Services sector, with a market value of about ₹7,247 crore.
The stock last traded at ₹1,665, against a 52-week range of ₹944–₹1,920 (13.3% below the high).
Before this filing the shares had moved −5.9% over the month and +28.2% over three months. Average daily turnover over the last 20 sessions was about ₹15.25 crore.
Promoters held 52.40% at the end of Q1 FY27, down 0.02% points from the previous quarter. Foreign institutions owned 4.37% and domestic institutions 15.48%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 1,404 | 27.8 | 6.39 |
| Q2 FY26 | 1,571 | 31.6 | 7.26 |
| Q3 FY26 | 1,707 | 27.6 | 6.35 |
| Q4 FY26 | 1,910 | 28 | 6.44 |
| Q1 FY27 | 1,940 | 38.2 | 8.77 |
What history shows
BCEIE's records show 3 previous results filings from the company since May 2026.
After those filings, the stock gained 0.5% on average the next trading day and was up 4.4% on average after five days (3 filings with price data).
Across 300 similar disclosures by other Consumer Services companies, shares moved −0.5% on average the next day and +0.2% over five days; 40% of them rose the next day.
Market-wide, 10,790 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 7 Aug 2026 | , the financial results for the period ended Jun 30, 2026. | +14.8% | +12.8% |
| 5 Aug 2026 | Revised intimation of the Earnings Call on the Unaudited Financial… | −1.3% | +15.0% |
| 25 May 2026 | Results - Financial Year 2025-26 | −12.2% | −14.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 4 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.